Upping the Ante to Lower Cholesterol

Upping the Ante to Lower Cholesterol

FRIDAY, Sept. 10 (HealthDayNews) -- Uh-oh, your lab results are back and your cholesterol''s in the danger zone. Your doctor has given you an ultimatum: Start exercising and watch your diet or you''ll have to start taking a cholesterol-busting statin drug.

Millions of American adults are being handed the same marching orders -- whip those cholesterol numbers into shape or go on a prescription medication.

American Heart Association - Co-authors are M. Fareed K. Suri, M.D.; Jawad F. Kirmani, M.D.; and Afshin A. Divani, Ph.D.

DALLAS, Sept. 3 – Smoking, high blood pressure and high cholesterol have taken a substantial toll on the American wallet.

When these cardiovascular risk factors led to a fatal heart attack or stroke in people who had not had a previous heart attack or stroke, it cost more than $13 billion in hospitalization and lost wages annually. When these uncontrolled risk factors lead to a recurrent heart attack or stroke that was fatal, it cost another $13 billion per year, according to research published in Stroke: Journal of the American Heart Association.

MONDAY, Aug. 23 (HealthDayNews) -- Blueberries, already the darlings of the fruit world for their potential disease-fighting ability, may have yet another compound to help lower cholesterol.

A compound called pterostilbene performed better, at least in a lab study with rats, than a common cholesterol-lowering drug. The compound might someday prove especially useful for people who don''t respond well to conventional anti-cholesterol drugs, according to a study presented Monday at the American Chemical Society annual meeting in Philadelphia.

TUESDAY, July 27 (HealthDayNews) -- If you''ve been paying any attention to medical news in the last few years, you''ve almost certainly heard the word "statins."

You may even have heard this question: "Could statins be the next miracle drug?"

TUESDAY, July 20 (HealthDayNews) -- For some unlucky people, high cholesterol is passed from one generation to the next; children who inherit the disorder, known as familial hypercholesterolemia, are at great risk of having a heart attack as early as their mid-20s.

"They develop coronary artery disease at a relatively young age," explained Dr. Albert Wiegman, a pediatric cardiologist at the Academic Medical Center in Amsterdam, the Netherlands.

American Heart Association - Co-authors are James I. Cleeman, M.D.; C. Noel Bairey Merz, M.D.; H. Bryan Brewer, Jr., M.D.; Luther T. Clark, M.D.; Donald B. Hunninghake, M.D. (until Dec. 2003); Richard C. Pasternak, M.D.; Sidney C. Smith, Jr., M.D.; and Neil J. Stone, M.D.

DALLAS, July 13 – Updated recommendations say more intensive cholesterol treatment is an option for people at high risk for heart attack and death from cardiovascular disease, according to updated recommendations from the National Cholesterol Education Program (NCEP).

The recommendations from a working group of NCEP’s Adult Treatment Panel III (ATP III) are published in today’s issue of Circulation: Journal of the American Heart Association. The National Heart, Lung, and Blood Institute, the American College of Cardiology and the American Heart Association endorse them.